SLNO logo

Soleno Therapeutics (SLNO) EBITDA

Annual EBITDA

-$173.63 M
-$136.60 M-368.90%

December 1, 2024


Summary


Performance

SLNO EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSLNOprofitabilitymetrics:

Quarterly EBITDA

-$49.48 M
+$29.36 M+37.24%

December 1, 2024


Summary


Performance

SLNO Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSLNOprofitabilitymetrics:

TTM EBITDA

-$173.63 M
-$36.82 M-26.91%

December 1, 2024


Summary


Performance

SLNO TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSLNOprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

SLNO EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-368.9%0.0%0.0%
3 y3 years-473.1%-747.5%-473.1%
5 y5 years-717.5%-575.1%-478.9%

SLNO EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-685.6%at low-956.7%+37.2%-685.6%at low
5 y5-year-717.5%at low-956.7%+37.2%-717.5%at low
alltimeall time<-9999.0%at low-2612.1%+37.2%-8916.0%at low

Soleno Therapeutics EBITDA History

DateAnnualQuarterlyTTM
Dec 2024
-$173.63 M(+368.9%)
-$49.48 M(-37.2%)
-$173.63 M(+26.9%)
Sep 2024
-
-$78.83 M(+246.7%)
-$136.81 M(+104.7%)
Jun 2024
-
-$22.74 M(+0.7%)
-$66.85 M(+28.7%)
Mar 2024
-
-$22.58 M(+78.4%)
-$51.93 M(+40.2%)
Dec 2023
-$37.03 M(+67.5%)
-$12.66 M(+42.7%)
-$37.03 M(+27.5%)
Sep 2023
-
-$8.87 M(+13.4%)
-$29.05 M(+12.6%)
Jun 2023
-
-$7.82 M(+1.8%)
-$25.79 M(+9.1%)
Mar 2023
-
-$7.68 M(+64.0%)
-$23.64 M(+7.0%)
Dec 2022
-$22.10 M(-27.0%)
-$4.68 M(-16.6%)
-$22.10 M(-5.0%)
Sep 2022
-
-$5.61 M(-1.1%)
-$23.26 M(-6.6%)
Jun 2022
-
-$5.67 M(-7.6%)
-$24.89 M(-7.1%)
Mar 2022
-
-$6.14 M(+5.2%)
-$26.78 M(-11.6%)
Dec 2021
-$30.30 M(+1.0%)
-$5.84 M(-19.4%)
-$30.30 M(-4.7%)
Sep 2021
-
-$7.24 M(-4.2%)
-$31.79 M(+2.1%)
Jun 2021
-
-$7.56 M(-21.7%)
-$31.14 M(-1.0%)
Mar 2021
-
-$9.65 M(+31.7%)
-$31.44 M(+4.8%)
Dec 2020
-$30.00 M(+41.2%)
-$7.33 M(+11.1%)
-$30.00 M(+3.2%)
Sep 2020
-
-$6.59 M(-16.1%)
-$29.06 M(+3.5%)
Jun 2020
-
-$7.86 M(-4.2%)
-$28.08 M(+11.6%)
Mar 2020
-
-$8.21 M(+28.5%)
-$25.16 M(+18.5%)
Dec 2019
-$21.24 M(+80.4%)
-$6.39 M(+13.8%)
-$21.24 M(+18.5%)
Sep 2019
-
-$5.62 M(+13.4%)
-$17.92 M(+15.9%)
Jun 2019
-
-$4.95 M(+15.6%)
-$15.46 M(+14.5%)
Mar 2019
-
-$4.28 M(+39.6%)
-$13.50 M(+14.7%)
DateAnnualQuarterlyTTM
Dec 2018
-$11.77 M(+4.7%)
-$3.07 M(-2.9%)
-$11.77 M(-15.9%)
Sep 2018
-
-$3.16 M(+5.7%)
-$14.00 M(+7.6%)
Jun 2018
-
-$2.99 M(+17.0%)
-$13.01 M(+3.8%)
Mar 2018
-
-$2.56 M(-51.8%)
-$12.54 M(+11.6%)
Dec 2017
-$11.24 M(+35.3%)
-$5.30 M(+143.9%)
-$11.24 M(+44.9%)
Sep 2017
-
-$2.17 M(-13.7%)
-$7.76 M(+2.7%)
Jun 2017
-
-$2.52 M(+100.7%)
-$7.55 M(+3.4%)
Mar 2017
-
-$1.25 M(-30.9%)
-$7.31 M(-29.0%)
Dec 2016
-$8.31 M(-31.1%)
-$1.82 M(-7.8%)
-$10.30 M(+36.8%)
Sep 2016
-
-$1.97 M(-13.3%)
-$7.53 M(-14.7%)
Jun 2016
-
-$2.27 M(-46.5%)
-$8.83 M(-7.9%)
Mar 2016
-
-$4.24 M(-545.5%)
-$9.58 M(+23.6%)
Dec 2015
-$12.05 M(+32.7%)
$952.50 K(-129.2%)
-$7.75 M(-46.5%)
Sep 2015
-
-$3.27 M(+7.8%)
-$14.49 M(+15.5%)
Jun 2015
-
-$3.03 M(+25.6%)
-$12.54 M(+16.0%)
Mar 2015
-
-$2.41 M(-58.3%)
-$10.81 M(+22.3%)
Dec 2014
-$9.08 M(+1027.9%)
-$5.78 M(+339.2%)
-$8.84 M(+138.3%)
Sep 2014
-
-$1.32 M(+1.3%)
-$3.71 M(+9.1%)
Jun 2014
-
-$1.30 M(+196.1%)
-$3.40 M(+3.3%)
Mar 2014
-
-$439.00 K(-32.9%)
-$3.29 M(+272.4%)
Dec 2013
-$804.90 K(-77.5%)
-$653.90 K(-35.1%)
-$884.10 K(+284.1%)
Sep 2013
-
-$1.01 M(-15.5%)
-$230.20 K(-129.6%)
Jun 2013
-
-$1.19 M(-160.5%)
$777.10 K(-60.5%)
Mar 2013
-
$1.97 M
$1.97 M
Dec 2012
-$3.57 M
-
-

FAQ

  • What is Soleno Therapeutics annual EBITDA?
  • What is the all time high annual EBITDA for Soleno Therapeutics?
  • What is Soleno Therapeutics annual EBITDA year-on-year change?
  • What is Soleno Therapeutics quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Soleno Therapeutics?
  • What is Soleno Therapeutics quarterly EBITDA year-on-year change?
  • What is Soleno Therapeutics TTM EBITDA?
  • What is the all time high TTM EBITDA for Soleno Therapeutics?
  • What is Soleno Therapeutics TTM EBITDA year-on-year change?

What is Soleno Therapeutics annual EBITDA?

The current annual EBITDA of SLNO is -$173.63 M

What is the all time high annual EBITDA for Soleno Therapeutics?

Soleno Therapeutics all-time high annual EBITDA is -$804.90 K

What is Soleno Therapeutics annual EBITDA year-on-year change?

Over the past year, SLNO annual EBITDA has changed by -$136.60 M (-368.90%)

What is Soleno Therapeutics quarterly EBITDA?

The current quarterly EBITDA of SLNO is -$49.48 M

What is the all time high quarterly EBITDA for Soleno Therapeutics?

Soleno Therapeutics all-time high quarterly EBITDA is $1.97 M

What is Soleno Therapeutics quarterly EBITDA year-on-year change?

Over the past year, SLNO quarterly EBITDA has changed by $0.00 (0.00%)

What is Soleno Therapeutics TTM EBITDA?

The current TTM EBITDA of SLNO is -$173.63 M

What is the all time high TTM EBITDA for Soleno Therapeutics?

Soleno Therapeutics all-time high TTM EBITDA is $1.97 M

What is Soleno Therapeutics TTM EBITDA year-on-year change?

Over the past year, SLNO TTM EBITDA has changed by $0.00 (0.00%)